Atlas Trials

A Study in Healthy Volunteers to Evaluate the Drug-Drug Interaction Potential of CCX168 With Concomitant Medications

Clinical trial NCT06004947 · COMPLETED

Trial details

NCT number
NCT06004947
Sponsor
Amgen
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis
Start date
2016-01-14
Primary completion
2016-03-15
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.